Course of antidepressant treatment, drug type, and prescriber's specialty

Psychiatric Services

Volumn 49, Issue 9, 1998, Pages 1180-1186

  Fairman, Kathleen A ^a,d   Drevets, Wayne C ^b   Kreisman, Jerold J ^c   Teitelbaum, Fred ^a  

^a Express Scripts   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c SSM Weight Loss Institute   (United States)

^d Express Scripts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; DATA BASE; DEPRESSION; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PRESCRIPTION; TREATMENT OUTCOME;

EID: 0031669533     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.49.9.1180     Document Type: Article

References (39)

1. Regier DA, Hirschfeld RMA, Goodwin FK, et al: The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis. American Journal of Psychiatry 145:1351-1357, 1988
2. Katon W, VonKorff M, Lin E, et al: Adequacy and duration of antidepressant treatment in primary care. Medical Care 30: 67-76, 1992
3. Keller MB, Klerman GL, Lavori PW, et al: Treatment received by depressed patients. JAMA 248:1848-1855, 1982
4. Keller MB, Lavori PW, Klerman GL, et al: Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Archives of General Psychiatry 43:458-466, 1986
5. Wells KB, Katon W, Rogers B, et al: Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the Medical Outcomes Study. American Journal of Psychiatry 151:694-700, 1994
6. Katon W, VonKorff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 273:1026-1031, 1995
7. Katon W, VonKorff M, Lin EH, et al: A randomized trial of psychiatric consultation with distressed high-utilizers. General Hospital Psychiatry 14:86-98, 1992
8. Katzelnick DJ, Kobak KA, Jefferson JW, et al: Prescribing patterns of antidepressant medications for depression in a HMO. Formulary 31:374-388, 1996
9. Simon GE, VonKorff M, Wagner EH, et al: Patterns of antidepressant use in community practice. General Hospital Psychiatry 15: 399-408, 1993
10. Fairman KA, Teitelbaum F, Drevets WC, et al: Course of antidepressant treatment with tricyclic versus selective serotonin reuptake inhibitor agents: a comparison in managed care and fee-for-service environments. American Journal of Managed Care 3:453-465, 1997
11. Simon GE, VonKorff M, Heiligenstein JH, et al: Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine versus tricyclic antidepressants. JAMA 275:1897-1902, 1996
12. Thompson C: Bridging the gap between psychiatric practice and primary care. International Clinical Psychopharmacology 7(suppl 2):31-36, 1992
13. Physicians' Desk Reference: Generics. Montvale, NJ, Medical Economics, 1995
14. VonKorff M, Wagner EH, Saunders K: A chronic disease score from automated pharmacy data. Journal of Clinical Epidemiology 45:197-203, 1992
15. Cooper-Patrick L, Crum RM, Ford DE: Characteristics of patients with major depression who received care in general medical and specialty mental health settings. Medical Care 32:15-24, 1994
16. Wells KB, Burnam MA, Camp P: Severity of depression in prepaid and fee-for-service general medical and mental health specialty practices. Medical Care 33:350-364, 1995
17. Sciar DA, Robison LM, Skaer TL, et al: Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization. Clinical Therapeutics 16:715-730, 1994
18. American Psychiatric Association Task Force on the Use of Laboratory Tests in Psychiatry: Tricyclic antidepressants: blood level measurements and clinical outcome: an APA task force report. American Journal of Psychiatry 142:155-162, 1985
19. Preskorn SH, Fast GA: Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness. Journal of Clinical Psychiatry 52(Aug suppl):23-33, 1991
20. Katon W, Gonzales J: A review of randomized trials of psychiatric consultation-liaison studies in primary care. Psychosomatics 35: 268-278, 1994
21. Brody DS, Larson DB: The role of primary care physicians in managing depression. Journal of General Internal Medicine 7: 243-247, 1992
22. Eisenberg L: Treating depression and anxiety in primary care: closing the gap between knowledge and practice. New England Journal of Medicine 326:1080-1084, 1992
23. Goldberg RJ: Psychiatry and the practice of medicine: the need to integrate psychiatry into comprehensive medical care. Southern Medical Journal 88:260-267, 1995
24. Hirschfeld RMA, Keller MB, Panico S, et al: The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 277:333-340, 1997
25. Wells KB, Sturm P: Care for depression in a changing environment. Health Affairs 14 (3):78-89, 1995
26. Anderson SM, Harthorn BH: Changing the psychiatric knowledge of primary care physicians: the effects of a brief intervention on clinical diagnosis and treatment. General Hospital Psychiatry 12:177-190, 1990
27. Callahan CM, Hendrie HC, Dittus RS, et al: Improving treatment of late life depression in primary care: a randomized clinical trial. Journal of the American Geriatrics Society 42:839-846, 1994
28. Fawcett J: Compliance: definitions and key issues. Journal of Clinical Psychiatry 56(Jan suppl):4-8, 1995
29. Gerber PD, Barrett JE, Barrett JA, et al: The relationship of presenting physical complaints to depressive symptoms in primary care patients. Journal of General Internal Medicine 7:170-173, 1992
30. Kessler LG, Cleary PD, Burke JD: Psychiatric disorders in primary care. Archives of General Psychiatry 42:583-587, 1985
31. Lin EHB, VonKorff M, Katon W, et al: The role of the primary care physician in patients' adherence to antidepressant therapy. Medical Care 33:67-74, 1995
32. Robinson P, Bush T, VonKorff M, et al: Primary care physician use of cognitive behavioral techniques with depressed patients. Journal of Family Practice 40:352-357, 1995
33. Andrews JM, Nemeroff CB: Contemporary management of depression. American Journal of Medicine 97(suppl 6A):24S-32S, 1994
34. Heiligenstein JH: Reformulating our formularies to reflect real-world outcomes. Drug Benefit Trends 8(8):35,42, 1996
35. Stokes PE: Fluoxetine: a five-year review. Clinical Therapeutics 15:216-243, 1993
36. Zetin M, Hansen J: Rational antidepressant selection. Comprehensive Therapy 20:209-223, 1994
37. Skaer TL, Sclar DA, Robison LM, et al: Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression. Current Therapeutic Research 56: 556-567, 1995
38. Smith W, Sherrill A: A pharmacoeconomic study of the management of major depression: patients in a TennCare HMO. Medical Interface 9(7):88-92, 1996
39. Thompson D, Buesching D, Gregor KJ, et al: Patterns of antidepressant use and their relation to costs of care. American Journal of Managed Care 2:1239-1246, 1996